It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
White adipose tissue (WAT) expansion in obesity occurs through enlargement of preexisting adipocytes (hypertrophy) and through formation of new adipocytes (adipogenesis). Adipogenesis results in WAT hyperplasia, smaller adipocytes and a metabolically more favourable form of obesity. How obesogenic WAT hyperplasia is induced remains, however, poorly understood. Here, we show that the mechanosensitive cationic channel Piezo1 mediates diet-induced adipogenesis. Mice lacking Piezo1 in mature adipocytes demonstrated defective differentiation of preadipocyte into mature adipocytes when fed a high fat diet (HFD) resulting in larger adipocytes, increased WAT inflammation and reduced insulin sensitivity. Opening of Piezo1 in mature adipocytes causes the release of the adipogenic fibroblast growth factor 1 (FGF1), which induces adipocyte precursor differentiation through activation of the FGF-receptor-1. These data identify a central feed-back mechanism by which mature adipocytes control adipogenesis during the development of obesity and suggest Piezo1-mediated adipocyte mechano-signalling as a mechanism to modulate obesity and its metabolic consequences.
Adipose tissue expansion occurs via enlargement of adipocytes as well as the generation of new fat cells, the latter being associated with more favorable metabolic outcomes. Here, the authors show that activation of adipocyte Piezo1 results in release of FGF1 and stimulates the differentiation of adipocyte precursor cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X); Xi’an Jiaotong University Health Science Center, Key Laboratory of Environment and Genes Related to Diseases, Cardiovascular Research Center, School of Basic Medical Sciences, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243)
2 Université Côte d’Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Labex ICST, Valbonne, France (GRID:grid.43169.39)
3 The University of Hong Kong, The State Key Laboratory of Pharmaceutical Biotechnology, Department of Pharmacology and Pharmacy, Hong Kong SAR, China (GRID:grid.194645.b) (ISNI:0000000121742757)
4 Xi’an Jiaotong University Health Science Center, Key Laboratory of Environment and Genes Related to Diseases, Cardiovascular Research Center, School of Basic Medical Sciences, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243)
5 Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X)
6 Goethe University, Institute for Vascular Signalling, Centre for Molecular Medicine, Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
7 Flow Cytometry Service Group, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (GRID:grid.418032.c)
8 First Affiliated Hospital of Xi’an Jiaotong University, Department of Hepatobiliary Surgery, Xi’an, China (GRID:grid.452438.c)
9 Xi’an Jiaotong University, Center for Mitochondrial Biology and Medicine, School of Life Science and Technology, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243)
10 Xi’an Jiaotong University Health Science Center, Department of Pharmacology, School of Basic Medical Sciences, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243)
11 Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X); Goethe University Frankfurt, Center for Molecular Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
12 Université Côte d’Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Labex ICST, Valbonne, France (GRID:grid.7839.5)